Muscle

68 drugs in development·43 companies·1 clinical trial

Drug Pipeline by Phase

Approved(16)

Drug	Company
amondys 45	Sarepta Therapeutics, Inc. (SRPT)
baclofen	ANI PHARMACEUTICALS INC (ANIP)
butalbital	Optec International, Inc. (GM)
butalbital	LANNETT CO INC (LCI)
butalbital	QIAGEN N.V. (QGEN)
cannabis	One World Products, Inc. (OWPC)
CARDIOLITE	Lantheus Holdings, Inc. (LNTH)
dysport	NEXIEN BIOPHARMA, INC. (NXEN)
exondys 51	Sarepta Therapeutics, Inc. (SRPT)
glycopyrrolate	Amneal Pharmaceuticals, Inc. (AMRX)
painshield md	ENvue Medical Inc. (FEED)
painshield plus	ENvue Medical Inc. (FEED)
ryanodex	EAGLE PHARMACEUTICALS, INC. (EGRX)
succinylcholine	NEXUS BIOPHARMA INC (NEXS)
vyondys 53	Sarepta Therapeutics, Inc. (SRPT)
zusduri	UroGen Pharma Ltd. (URGN)

Phase 3(24)

Drug	Company
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide	Crinetics Pharmaceuticals, Inc. (CRNX)
bacillus calmette guerin	GH Research PLC (GHRS)
bacillus calmette-guerin	ASTRAZENECA PLC (AZN)
bcg	ASTRAZENECA PLC (AZN)
BCG	ImmunityBio, Inc. (IBRX)
bcg + n-803	ImmunityBio, Inc. (IBRX)
Botulinum Toxin Type A	AbbVie Inc. (ABBV)
cretostimogene	CG Oncology, Inc. (CGON)
cretostimogene grenadenorepvec	CG Oncology, Inc. (CGON)
enfortumab vedotin	ASTRAZENECA PLC (AZN)
enobosarm	VERU INC. (VERU)
mitomycin c	GH Research PLC (GHRS)
MMC	Merus N.V. (MRUS)
N-803 and BCG	ImmunityBio, Inc. (IBRX)
nadofaragene firadenovec	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Nadofaragene Firadenovec	Merus N.V. (MRUS)
Nadofaragene Firadenovec	Valneva SE (VALN)
plx-pad	Pluri Inc. (PLUR)
Supportive care measures	Merck & Co., Inc. (MRK)
tar-200	GH Research PLC (GHRS)
TAR-200	CG Oncology, Inc. (CGON)
tar-210	GH Research PLC (GHRS)
TAR-210	Merus N.V. (MRUS)

Phase 2(7)

Drug	Company
ARV-027	ARVINAS, INC. (ARVN)
BOTOX	AbbVie Inc. (ABBV)
lp-50	LIPELLA PHARMACEUTICALS INC. (LIPO)
pentadecapeptide bpc 157	IO Biotech, Inc. (IOBT)
Platelet rich plasma	Revance Therapeutics, Inc. (RVNC)
Relatlimab	ENANTA PHARMACEUTICALS INC (ENTA)
tara-002	Protara Therapeutics, Inc. (TARA)

Phase 1(6)

Drug	Company
ANPA-0073	Structure Therapeutics Inc. (GPCR)
AU-011	Aura Biosciences, Inc. (AURA)
cg0070	GH Research PLC (GHRS)
el-22	PMGC Holdings Inc. (ELAB)
ugn-201	UroGen Pharma Ltd. (URGN)
ugn-301	UroGen Pharma Ltd. (URGN)

Preclinical(10)

Drug	Company
activated cannabinoid	Phoenix Life Sciences International Limited. (PLSI)
ADX-743	Aldeyra Therapeutics, Inc. (ALDX)
cannabis-derived products	One World Products, Inc. (OWPC)
ck-089	CYTOKINETICS INC (CYTK)
el-32	PMGC Holdings Inc. (ELAB)
musclin	INNOVUS PHARMACEUTICALS, INC. (INNV)
myostatin x activin a bispecific antibody	iBio, Inc. (IBIO)
regenerum	INNOVUS PHARMACEUTICALS, INC. (INNV)
uio-524	Transcode Therapeutics, Inc. (RNAZ)
wynovia	BIOADAPTIVES, INC. (BDPT)

Unknown(3)

Drug	Company
FitYourOutfit® (FYO) Body Composition System	BIOADAPTIVES, INC. (BDPT)
Icy Muscle Gel 500mg (Broad Spectrum topical)	Charlie's Holdings, Inc. (CHUC)
ProteinNMore™	BIOADAPTIVES, INC. (BDPT)

Phase 1/Phase 2(1)

Drug	Company
erdafitinib intravesical delivery system	GH Research PLC (GHRS)

Phase 4(1)

Drug	Company
prabotulinumtoxinA-xvfs	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 68 drugs in development for Muscle across 43 companies.

There are 1 clinical trial targeting Muscle tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.